1997
Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography.
Rofsky N, Johnson G, Adelman M, Rosen R, Krinsky G, Weinreb J. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 1997, 205: 163-9. PMID: 9314979, DOI: 10.1148/radiology.205.1.9314979.Peer-Reviewed Original ResearchConceptsPeripheral vascular diseaseGadolinium-enhanced MR angiographyDigital subtraction angiographyVascular diseaseMR angiographyGadopentetate dimeglumineLower extremity peripheral vascular diseasePeripheral vascular areasExtent of diseaseMR angiography findingsGadolinium-enhanced magnetic resonance angiographyMagnetic resonance angiographyConventional digital subtraction angiographyStandard of referenceAngiography findingsMost patientsLess stenosisTreatment optionsLower extremitiesDSA findingsVascular areaAngiographyAnatomic segmentsAnatomic areasContrast materialGadolinium-enhanced body MR venography with subtraction technique.
Lebowitz J, Rofsky N, Krinsky G, Weinreb J. Gadolinium-enhanced body MR venography with subtraction technique. American Journal Of Roentgenology 1997, 169: 755-8. PMID: 9275892, DOI: 10.2214/ajr.169.3.9275892.Peer-Reviewed Original ResearchSuppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine.
Rofsky N, Purdy D, Johnson G, DeCorato D, Earls J, Krinsky G, Weinreb J. Suppression of venous signal in time-of-flight MR angiography of the lower extremities after administration of gadopentetate dimeglumine. Radiology 1997, 202: 177-82. PMID: 8988209, DOI: 10.1148/radiology.202.1.8988209.Peer-Reviewed Original ResearchConceptsGadopentetate dimeglumineLower extremitiesMR angiographyPeripheral vascular diseaseVenous signalDistal lower extremityMR angiogramsGadopentetate dimeglumine administrationStudent's t-testFlight MR angiographyAdult patientsAngiography timeVascular diseaseFlight MR angiogramsGradient echo sequenceAdministrationDimegluminePatientsAngiographyT-testAngiogramsExtremitiesMuscle tissueVenous suppressionImaging sectionsThoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging.
Krinsky G, Rofsky N, DeCorato D, Weinreb J, Earls J, Flyer M, Galloway A, Colvin S. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997, 202: 183-93. PMID: 8988210, DOI: 10.1148/radiology.202.1.8988210.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAorta, ThoracicAortic Aneurysm, ThoracicAortic CoarctationAortic DiseasesAortic DissectionContrast MediaDrug CombinationsFemaleGadoliniumGadolinium DTPAHumansImage Processing, Computer-AssistedInfant, NewbornMagnetic Resonance AngiographyMagnetic Resonance ImagingMaleMeglumineMiddle AgedOrganometallic CompoundsPentetic AcidRetrospective StudiesConceptsThoracic aortic diseaseThree-dimensional MR angiographyConventional MR imagingMR angiographyIntramural hematomaAortic dissectionAortic diseaseVessel diseaseMR imagingFindings of surgeryChronic aortic dissectionThoracic MR imagingComparison of gadoliniumMagnetic resonance angiographyThree-dimensional magnetic resonance angiographyDiagnosis of aneurysmConsecutive patientsAngiographyResonance angiographyMR examinationsGadopentetate dimeglumineReader B.DiseaseGradient echo sequenceConventional MRHepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector.
Earls J, Rofsky N, DeCorato D, Krinsky G, Weinreb J. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 1997, 202: 268-73. PMID: 8988222, DOI: 10.1148/radiology.202.1.8988222.Peer-Reviewed Original Research
1996
Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector.
Earls J, Rofsky N, DeCorato D, Krinsky G, Weinreb J. Breath-hold single-dose gadolinium-enhanced three-dimensional MR aortography: usefulness of a timing examination and MR power injector. Radiology 1996, 201: 705-10. PMID: 8939219, DOI: 10.1148/radiology.201.3.8939219.Peer-Reviewed Original ResearchGadolinium-enhanced three-dimensional MR angiography of acquired arch vessel disease.
Krinsky G, Rofsky N, Flyer M, Giangola G, Maya M, DeCoroto D, Earls J, Weinreb J. Gadolinium-enhanced three-dimensional MR angiography of acquired arch vessel disease. American Journal Of Roentgenology 1996, 167: 981-7. PMID: 8819398, DOI: 10.2214/ajr.167.4.8819398.Peer-Reviewed Original ResearchAsymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine.
Walsh P, Rofsky N, Krinsky G, Weinreb J. Asymmetric signal intensity of the renal collecting systems as a sign of unilateral renal artery stenosis following administration of gadopentetate dimeglumine. Journal Of Computer Assisted Tomography 1996, 20: 812-4. PMID: 8797919, DOI: 10.1097/00004728-199609000-00025.Peer-Reviewed Original ResearchNonspecificity of short inversion time inversion recovery (STIR) as a technique of fat suppression: pitfalls in image interpretation.
Krinsky G, Rofsky N, Weinreb J. Nonspecificity of short inversion time inversion recovery (STIR) as a technique of fat suppression: pitfalls in image interpretation. American Journal Of Roentgenology 1996, 166: 523-6. PMID: 8623620, DOI: 10.2214/ajr.166.3.8623620.Peer-Reviewed Original Research
1995
Ureteral lymphoma: MRI demonstration
Lebowitz J, Rofsky N, Weinreb J, Friedmann P. Ureteral lymphoma: MRI demonstration. Abdominal Radiology 1995, 20: 173-175. PMID: 7787726, DOI: 10.1007/bf00201532.Peer-Reviewed Original Research
1994
Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine
Rofsky N, Pizzarello D, Weinreb J, Ambrosino M, Rosenberg C. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. Journal Of Magnetic Resonance Imaging 1994, 4: 805-807. PMID: 7865940, DOI: 10.1002/jmri.1880040611.Peer-Reviewed Original ResearchMeSH KeywordsAnalysis of VarianceAnimalsBody WeightContrast MediaDrug CombinationsEar, ExternalEmbryonic and Fetal DevelopmentExtremitiesEyeFemaleFetal DeathGadoliniumGadolinium DTPAGestational AgeHeadLitter SizeMagnetic Resonance ImagingMeglumineMiceOrganometallic CompoundsPentetic AcidPregnancySodium ChlorideConceptsDays of gestationIntraperitoneal injectionGadopentetate dimeglumineFetal weightEnd pointMR exposureMean fetal weightSaline injection groupMagnetic resonance exposurePregnant miceNormal salineFetal mouse developmentGroup 2Group 1Group 3Control groupGroup 4Group 5MR imagingAdverse effectsDimeglumineSignificant differencesGestationFetusesInjection
1993
Use of the Magnetic Resonance Contrast Agent Gadodiamide in the Central Nervous System Results of a Multicenter Trial
SZE G, BRANT-ZAWADZKI M, McNAMARA M, HAUGHTON V, KUMAR A, MARAVILLA K, AISEN A, DREISBACH J, BRADLEY W, WEINREB J, DRAYER B, TSURUDA J, HESSELINK J, JOHNSON C, ZIMMERMAN R, WEINGAST G. Use of the Magnetic Resonance Contrast Agent Gadodiamide in the Central Nervous System Results of a Multicenter Trial. Investigative Radiology 1993, 28: s49-s55. PMID: 8486504, DOI: 10.1097/00004424-199303001-00006.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingPhase II/III clinical trialsVital signsCentral nervous system resultsSignificant adverse eventsNervous system resultsNonionic contrast agentsVisualization of lesionsPreinjection imagesAdverse eventsNeurologic statusMulticenter trialClinical statusMulticenter studyClinical trialsPatient's vital signsMRI scansGadodiamide injectionPatientsResonance imagingSafety parametersContrast enhancementInjectionTrialsSpineQuantitative analysis of gadopentetate dimeglumine excreted in breast milk
Rofsky N, Weinreb J, Litt A. Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. Journal Of Magnetic Resonance Imaging 1993, 3: 131-132. PMID: 8428080, DOI: 10.1002/jmri.1880030122.Peer-Reviewed Original Research
1991
Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
Sze G, Brant-Zawadzki M, Haughton V, Maravilla K, McNamara M, Kumar A, Aisen A, Dreisbach J, Bradley W, Weinreb J. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991, 181: 693-9. PMID: 1947084, DOI: 10.1148/radiology.181.3.1947084.Peer-Reviewed Original ResearchConceptsCentral nervous systemGadodiamide injectionNervous systemMR imagingSerious adverse eventsContrast material enhancementVisualization of lesionsMagnetic resonance imagingNeurologic statusAdverse eventsMulticenter studyLaboratory valuesPatientsResonance imagingVital signsLesionsUnenhanced imagesSpinePhase IIInjectionMaterial enhancementContrast agentsMR imagesGadolinium chelate complexesImagingRenal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency.
Rofsky N, Weinreb J, Bosniak M, Libes R, Birnbaum B. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991, 180: 85-9. PMID: 2052729, DOI: 10.1148/radiology.180.1.2052729.Peer-Reviewed Original ResearchConceptsRenal insufficiencyGadolinium-enhanced MR imagingRenal lesionsComputed tomographyGadolinium administrationBenign cystsMR imagingSerum creatine levelsTime of nephrectomyNonenhanced Computed TomographyRenal cell carcinomaT1-weighted magnetic resonanceRenal lesion characterizationFifth patientPathologic examinationNephrotoxic reactionsUsual dosageCell carcinomaIntravenous administrationCreatine levelsMagnetic resonancePatientsIntravenous gadoliniumLesionsGadopentetate dimeglumine
1990
Pulmonary Artery Sarcoma
Weinreb J, Davis S, Berkmen Y, Isom W, Naidich D. Pulmonary Artery Sarcoma. Journal Of Computer Assisted Tomography 1990, 14: 647-649. PMID: 2370363, DOI: 10.1097/00004728-199007000-00025.Peer-Reviewed Original Research